Please login to the form below

Not currently logged in


This page shows the latest tofacitinib news and features for those working in and with pharma, biotech and healthcare.

GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

This includes its CDK 4/6 inhibitor Ibrance (palbociclib),  which grew by 27% to $1.3bn in the last quarter, and its fast-growing oral JAK inhibitor Xeljanz (tofacitinib).

Latest news

More from news
Approximately 9 fully matching, plus 65 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...